Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
about
Medicare Part D and quality of prescription medication use in older adultsMedicare part d and the federal employees health benefits program: a comparison of prescription drug coverage.Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.Medicare Part D's effect on the under- and overuse of medications: a systematic review.Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.Use of medications of questionable benefit in advanced dementia.Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents.A critical review of methods to evaluate the impact of FDA regulatory actions.Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home Residents.Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults'.Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents.Effect of total exemption from medical service co-payments on potentially inappropriate medication use among elderly ambulatory patients in a single center in Japan: a retrospective cross-sectional study.
P2860
Q27023843-EED594BE-D057-4608-B1F0-CE858F4B1C21Q33652790-A13EFC82-B509-418D-A7AB-1409BB2C2DB8Q35291961-2CFC3E77-8B56-4E74-A7EC-B3D0A183743DQ35470790-64807788-CAAA-45F0-BAEE-FD6EC05BD76EQ36105740-2391D2B0-200D-4F5A-8796-B31F48A513FFQ36165497-71BFE1DC-E195-459B-B8B1-A4C8FAC77944Q36398853-1A072A68-4022-4AC9-84F1-871B4063A06CQ36913286-A465B9DC-0EAD-4CD1-B08D-1275B3384A41Q37301216-82AD2CE6-6109-42AA-A281-3A273D393756Q38111298-1C385D3D-32A1-49F1-8BFD-6D605E323C64Q38915260-C2C97A19-E023-474A-900F-2DAF04E0B1EDQ44349136-32ED6C99-426B-4320-91DB-16705B07AAB5Q44608178-2DA120D6-F723-4BA5-A8CD-3FE185C54F41Q47908138-7936255F-FDE1-46BB-B845-D1EE253EF528Q54963186-5954F21F-5CC7-41F3-8A49-80117913048C
P2860
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@ast
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@en
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@nl
type
label
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@ast
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@en
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@nl
prefLabel
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@ast
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@en
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@nl
P2093
P2860
P1476
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
@en
P2093
Becky A Briesacher
Hassan Fouayzi
Jerry H Gurwitz
Stephen B Soumerai
Terry S Field
P2860
P304
P356
10.1001/ARCHINTERNMED.2010.57
P407
P577
2010-04-01T00:00:00Z